The role of elastography in non-alcoholic fatty liver disease

被引：9

作者：

Liguori, Antonio ^{[1
]}

Ainora, Maria E. ^{[1
]}

Riccardi, Laura ^{[1
]}

De Matthaeis, Nicoletta ^{[1
]}

Pizzolante, Fabrizio ^{[1
]}

Gasbarrini, Antonio ^{[1
,2
]}

Zocco, Maria A. ^{[1
,2
]}

Grieco, Antonio ^{[1
,2
]}

Rapaccini, Gianludovico ^{[1
,2
]}

Miele, Luca ^{[1
,2
]}

机构：

[1] Sacred Heart Catholic Univ, IRCCS A Gemelli Univ Polyclin Fdn, Dept Med & Surg Sci, Largo Gemelli 8, I-00168 Rome, Italy

[2] Sacred Heart Catholic Univ, Dept Med & Translat Surg, Rome, Italy

来源：

MINERVA GASTROENTEROLOGY | 2021年 / 67卷 / 02期

关键词：

Non-alcoholic fatty liver disease; Review; Gastroenterology; MAGNETIC-RESONANCE ELASTOGRAPHY; RADIATION FORCE IMPULSE; TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; DIAGNOSTIC-ACCURACY; NONINVASIVE TOOLS; FIBROSIS; METAANALYSIS; PERFORMANCE; MANAGEMENT;

D O I：

10.23736/S2724-5985.21.02801-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its prevalence is even higher in patients with risk factors such as type 2 diabetes and obesity. Liver biopsy is the gold standard for diagnosis of non-alcoholic steatohepatitis (NASH), particularly for the assessment of fibrosis stage that is a key prognostic factor. Noninvasive methods for assessment of liver fibrosis are a huge need in contemporary hepatology in order to stratify patient's risk of advanced and progressive liver disease. In this perspective different imaging techniques have been developed in last decades and showed high performance in liver fibrosis evaluation. Strengths and weaknesses of all imaging methods are summarized in this review.

引用

页码：164 / 170

页数：7

共 50 条

[31] Role of ezetimibe in non-alcoholic fatty liver disease
Filippatos, Theodosios D.
Elisaf, Moses S.
WORLD JOURNAL OF HEPATOLOGY, 2011, 3 (10) : 265 - 267
[32] Role of hepatokines in non-alcoholic fatty liver disease
Ke, Yini
Xu, Chengfu
Lin, Jin
Li, Youming
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE, 2019, 7 (04) : 143 - 148
[33] Doppler perfusion index in adolescents with non-alcoholic fatty liver disease
Riahinezhad, Maryam
Saneian, Hossein
Farghadani, Maryam
Arshad, Shafigheh Parsai
IMMUNOPATHOLOGIA PERSA, 2021, 7 (01):
[34] Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts
Papatheodoridi, Margarita
Cholongitas, Evangelos
CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (38) : 4574 - 4586
[35] The evaluation of non-alcoholic fatty liver disease in children with obesity with vibration-controlled transient elastography
Arsoy, Hanife Aysegul
Kara, Ozlem
Keskin, Murat
JOURNAL OF CLINICAL ULTRASOUND, 2024, 52 (06) : 723 - 730
[36] Non-invasive diagnosis and staging of non-alcoholic fatty liver disease
Kechagias, Stergios
Ekstedt, Mattias
Simonsson, Christian
Nasr, Patrik
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 21 (03): : 349 - 368
[37] The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease
Winarto, Jessica
Song, Dae-Geun
Pan, Cheol-Ho
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
[38] Role of Leptin in Non-Alcoholic Fatty Liver Disease
Jimenez-Cortegana, Carlos
Garcia-Galey, Alba
Tami, Malika
del Pino, Pilar
Carmona, Isabel
Lopez, Soledad
Alba, Gonzalo
Sanchez-Margalet, Victor
BIOMEDICINES, 2021, 9 (07)
[39] A comparison of magnetic resonance elastography (MRE) to biomarker testing for staging fibrosis in non-alcoholic fatty liver disease (NAFLD)
Kaplan, Joseph M.
Alexis, Jamil
Grimaldi, Gregory
Islam, Mohammed
Izard, Stephanie M.
Lee, Tai-Ping
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 8
[40] Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Tincopa, Monica A.
Loomba, Rohit
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 660 - 670

← 1 2 3 4 5 →